Title | Description |
|---|---|
| Trial ID | KF5503/12 |
| Compound | Tapentadol |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 3 |
| Brief title | A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee |
| Indication | Chronic pain, knee osteoarthritis |
| UTN | |
| CTG ID | NCT00486811 |
| CTIS ID (former EudraCT) | 2006-005783-67 |
| Trial status | Completed |
| FPI | June 4, 2007 |
| LPO | July 18, 2008 |
| Countries | Germany, Hungary, Italy, Latvia, Netherlands, Poland, Portugal, Romania, Spain, Austria, Croatia, Slovakia, United Kingdom, Netherlands |
| Gender | All |
| Age | > 40 |
| Results | Yes |
| Pubmed | 28537501 24985410 24916058 24353047 23709304 23340531 |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.